Observations placeholder
Voriconazole
Identifier
020376
Type of Spiritual Experience
Background
A description of the experience
Voriconazole (, brand name Vfend,) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.
Side effects
The most common side effects associated with voriconazole include transient visual disturbances, fever, rash, vomiting, nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain, and respiratory disorder.
Unlike most adverse effects, which are similar to other azole antifungal agents, visual disturbances (such as blurred vision or increased sensitivity to light) are unique to voriconazole. These have been reported by more than 30% of patients in clinical trials. They generally occur approximately one-half hour after administration, and last approximately 30 minutes. In some patients they may go away after continued use. Studies have shown that there is no damage to the eye or long-term effect on vision. However, patients taking voriconazole should be advised against driving at night or other potentially hazardous tasks.
Though rare, there have been cases of serious hepatic reactions during treatment with voriconazole (a class effect of azole antifungal agents). Liver function tests should be evaluated at the start of and during the course of therapy.
Voriconazole is phototoxic. It has been associated with an increased risk of squamous-cell carcinoma of the skin.
On Dec, 24, 2016 4,951 people reported to have side effects when taking Voriconazole. Among them, 99 people (2.0%) have Hallucination
Time on Voriconazole when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 92.31% | 7.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Voriconazole :
| Female | Male | |
| Hallucination | 30.43% | 69.57% |
Age of people who have Hallucination when taking Voriconazole :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 4.55% | 6.82% | 13.64% | 2.27% | 27.27% | 45.45% |
On Jan, 29, 2016: 2,850 people reported to have side effects when taking Voriconazole. Among them, 126 people (4.42%) have Death.
Time on Voriconazole when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 87.18% | 12.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Voriconazole :
| Female | Male | |
| Death | 32.10% | 67.90% |
Age of people who have Death when taking Voriconazole :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 1.17% | 9.94% | 5.26% | 2.34% | 8.77% | 37.43% | 35.09% |
Top conditions involved for these people :
- Aspergillosis (120 people, 95.24%)